 NeuroMetrix Inc NASDAQ: NURO has reported that top-line results from a randomized controlled trial of Quell for fibromyalgia will be presented at two upcoming pain medicine conferences. Quell is a transcutaneous electrical nerve stimulator indicated for symptomatic relief and management of chronic lower extremity pain and is available over-the-counter. 